Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
08/04/2010 | EP2213663A1 Preparation of halogenated N-heteroaromatic polyhalogen derivatives |
08/04/2010 | EP2213281A1 Pharmaceutical composition comprising N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride |
08/04/2010 | EP2212298A1 Deuterated etravirine |
08/04/2010 | EP2212297A1 Inhibitors of protein kinases |
08/04/2010 | EP1392660B1 Substituted benzoylcyclohexenones and their use as herbicidal agents |
08/04/2010 | CN101796031A Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
08/04/2010 | CN101795566A Co-crystals of pyrimethanil and dithianon |
08/04/2010 | CN101792440A Quinazolinone derivatives, preparation and application thereof |
08/04/2010 | CN101792420A Preparation of halogenated n-heteroaromatic polyhalogen derivatives |
08/04/2010 | CN101130542B Synthesis method of antiviral nucleoside analogue |
08/03/2010 | US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
08/03/2010 | US7767680 4-phenylpyrimidine compounds such as 4-(2-Fluoro-phenyl)-2-morpholin-4-yl-pyrimidine-5-carboxylic acid benzyl-isopropyl-amide, useful as inhibitors of voltage-gated sodium channels and/or calcium channels, for the treatment of pain, psychological and neurodegenerative disorders |
08/03/2010 | US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
08/03/2010 | US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators |
08/03/2010 | US7767669 inhibitors of phosphatidyl inositol (PI) 3-kinase, such as 4-(1H-indazol-5-ylamino)-6- (4-methoxy-3- methylphenyl)-2-morpholin- 4-ylpyrimidine-5-carboxylic acid, used for the treatment of breast cancer |
08/03/2010 | US7767667 Pesticidal heterocycles |
08/03/2010 | US7767624 3-Heterocyclyl substituted benzoic acid derivatives |
08/03/2010 | US7767623 agricultural fungicides; silane or silanol substituted hetero(thio)carbonylaminobenzene compounds; corresponding anilino intermediates |
07/29/2010 | WO2010085128A2 Processes for preparing hiv reverse transcriptase inhibitors |
07/29/2010 | WO2010084050A2 Quinazolinone derivatives useful as vanilloid antagonists |
07/29/2010 | WO2009153457A3 Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action |
07/29/2010 | US20100190983 Process for preparing voriconazole |
07/29/2010 | US20100190982 Process for the preparation of lamivudine form i |
07/29/2010 | US20100190977 4-phenylamino-quinazolin-6-yl-amides |
07/29/2010 | US20100190808 Tricyclic Compounds As Modulators of TNF-alpha Synthesis |
07/29/2010 | US20100190803 Bis(styryl)pyrimidine or bis(styryl)benzene compounds, pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition for prevention or treatment of diseases featuring amyloids comprising the same as an active ingredient |
07/29/2010 | US20100190746 Quinazolinones as potassium channel modulators |
07/29/2010 | US20100189796 Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile |
07/29/2010 | US20100189648 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof |
07/29/2010 | US20100188618 Liquid-crystal display |
07/29/2010 | US20100187505 Benzanthracene derivatives for organic electroluminescent devices |
07/29/2010 | CA2749529A1 Quinazolinone derivatives useful as vanilloid antagonists |
07/28/2010 | EP2210892A2 Neurologically-active compounds |
07/28/2010 | EP2210880A1 Benzoxazinone derivative |
07/28/2010 | EP2210879A1 Pyrimidine derivatives and use thereof for combating undesired plant growth |
07/28/2010 | EP2209775A1 Heterobicyclic compounds as histamine h4-receptor antagonists |
07/28/2010 | EP2209761A1 Diphenyl substituted cycloalkanes |
07/28/2010 | EP2209390A1 Complex product with advanced assimilation efficacy for humans and its utilization |
07/28/2010 | EP1971579B1 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides |
07/28/2010 | EP1369418B1 Quinazoline derivatives |
07/28/2010 | CN1845907B Guanidine derivatives |
07/28/2010 | CN101790519A 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis |
07/28/2010 | CN101790518A Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
07/28/2010 | CN101787019A Quinazoline derivatives |
07/28/2010 | CN101787017A Optical pure quinazoline compound |
07/28/2010 | CN101786997A Amino acid and pesticide coupling compound as well as preparation method and application thereof as pesticide |
07/28/2010 | CN101786996A Amino acid and pesticide coupling compound as well as preparation method and application thereof as pesticide |
07/28/2010 | CN101786991A Substituted tetracycline compounds |
07/27/2010 | US7763632 administering drugs succh as N-[2-diethylamino-5-{N-ethyl-N-(trifluoroacetyl)amino}pyrimidin-4-yl]-L-4'-{(pyrrolidin-1-yl) carbonyloxy}phenylalanine, for the treament asthma, multiple sclerosis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, graft versus host disease and arthritis |
07/27/2010 | US7763631 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
07/27/2010 | US7763628 Quinazolinones useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity; N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide monomethanesulfonate |
07/27/2010 | US7763627 2-pyridin-4-ylquinazolin-4- amine's such as N-cyclohexyl-2-pyridin-4-ylquinazolin-4- amine, used as tyrosine kinase inhibitors, for modulating cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion; antiproliferative agents and angiogenesis inhibitors |
07/27/2010 | US7763616 Chemokine receptor antagonists, used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, hypersensitivity responses, ophthalmic inflammation, diabetes, viral meningitis and tumors |
07/27/2010 | CA2631535C Spirocyclic quinazoline derivatives as pde7 inhibitors |
07/27/2010 | CA2546701C Crystalline ammonium salts of rosuvastatin |
07/27/2010 | CA2436659C Cannabinoid receptor ligands |
07/22/2010 | WO2010083241A2 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders |
07/22/2010 | WO2010082072A1 Process for the preparation of rosuvastatin salts |
07/22/2010 | WO2010081861A1 Process for the preparation of rosuvastatin |
07/22/2010 | WO2010045379A3 Pyridine non-classical cannabinoid compounds and related methods of use |
07/22/2010 | WO2009157014A3 A process for preparing hmg-coa reductase inhibitors and intermediates |
07/22/2010 | US20100184979 New process for preparing 2-(3--phenyl)-2-methylproprionic acid |
07/22/2010 | US20100184977 Nickel or Iron Catalysed Carbon-Carbon Coupling Reaction of Arylenes, Alkenes and Alkines |
07/22/2010 | US20100184974 Protease Inhibitors |
07/22/2010 | US20100184789 Inhibitors of protein kinases |
07/22/2010 | US20100184788 Heterocyclic derivatives |
07/22/2010 | US20100184787 Heataryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
07/22/2010 | US20100184786 Polar Quinazolines |
07/22/2010 | US20100184780 Inhibitors of protein kinases |
07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
07/22/2010 | US20100183606 Monocyclic heterocycles as kinase inhibitors |
07/22/2010 | US20100183563 Dentinogenesis promoter and dentinogenic pulp-capping material |
07/22/2010 | CA2749727A1 Process for the preparation of rosuvastatin salts |
07/22/2010 | CA2749157A1 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders |
07/21/2010 | EP2207876A1 Stereo-specific hydroxylation |
07/21/2010 | EP1265866B1 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
07/21/2010 | CN1964954B Pyrazolo pyrimidines |
07/21/2010 | CN1960977B Quinazoline derivative |
07/21/2010 | CN1954446B 有机电致发光元件 Organic electroluminescent element |
07/21/2010 | CN1826310B Novel aminobenzophenone compounds |
07/21/2010 | CN1751031B HIV replication inhibiting pyrimidines |
07/21/2010 | CN101784532A Novel HIV reverse transcriptase inhibitors |
07/21/2010 | CN101784531A 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides |
07/21/2010 | CN101784530A 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors |
07/21/2010 | CN101784276A Use of compounds for preparing anti-tuberculosis agents |
07/21/2010 | CN101781273A dipeptidylpeptidase iv inhibitor containing guanidyl |
07/21/2010 | CN101781265A Conjugate of amino acid and pesticide and preparation method thereof and application thereof as pesticide |
07/21/2010 | CN101781259A Precursor compound of 18F marked tumor inhibitor Monastrol as well as preparation method and application |
07/21/2010 | CN101781258A Dihydro pyrimidone sulfoacid as well as salt compound and preparation method thereof |
07/21/2010 | CN101041635B Method for synthesizing ketenes amine condensation derivatives |
07/20/2010 | US7759487 such as 1-(2,4-dimethylpyrimidine-5-carbonyl)-4-piperidone; useful as intermediates for preparation of antagonists of chemokine receptor (CCR5), for the treatment of HIV and AIDS |
07/20/2010 | US7759486 2,4,5-Trisubstituted pyrimidine compounds |
07/20/2010 | US7759379 Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
07/20/2010 | US7759357 N-[4-3-chloro-phenyl)-pyrimidin-2-yl]-N-(4-trifluoromethyl-phenyl)-amine, having immunoglobulin E (IgE) synthesis inhibiting activity, used for treating rheumatoid arthritis |
07/20/2010 | US7759356 administering adenosine receptors antagonists, such as 2-amino-4-phenyl-indeno[1,2-d]pyrimidin-5-one, for the treatment of neurodegenerative diseases; Parkinson's Disease |
07/20/2010 | US7759353 Substituted spiro iminopyrimidinones as aspartyl protease inhibitors, compositions, and methods of treatment |
07/20/2010 | US7759350 Pyrimidine carboxamides |
07/20/2010 | US7759345 ecteinascidins used for treating lung, colon, kidney, prostate, ovarian, breast and pancreatic cancers, leukaemia or melanoma |
07/20/2010 | US7759342 such as 8-(2-Fluorophenylamino)-2-(4-methoxyphenylamino)-9-(trans-4-(methylamino)cyclohexyl)-9H-purine, used for for inhibiting neutrophil accumulation in bronchoalveolar lavage fluid |
07/20/2010 | US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus |